γ-irradiation deregulates cell cycle control and apoptosis in nevoid basal cell carcinoma syndrome-derived cells

Japanese Journal of Cancer Research

Volumn 90, Issue 12, 1999, Pages 1351-1357

  Fujii, Katsunori ^a,b   Miyashita, Toshiyuki ^a   Takanashi, Jun Ichi ^b   Sugita, Katsuo ^b   Kohno, Yoichi ^b   Nishie, Haruko ^c   Yasumoto, Shin Ichiro ^c   Furue, Masutaka ^c   Yamada, Masao ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

Cell cycle; NBCCS; p27; irradiation

Indexed keywords

PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BASAL CELL NEVUS SYNDROME; CARCINOGENESIS; CASE REPORT; CELL CYCLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GAMMA IRRADIATION; GENE DELETION; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 0033378326     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00719.x     Document Type: Article

References (35)

1. Gorlin, R. J. and Goltz, R. W. Multiple nevoid basal-cell epithelioma, jaw cysts and bifid rib. A syndrome. N. Engl. J. Med., 262, 908-912 (1960).
2. Evans, D. G., Ladusans, E. J., Rimmer, S., Burnell, L. D., Thakker, N. and Farndon, P. A. Complication of the nevoid basal cell carcinoma syndrome: results of a population based study. J. Med. Genet., 30, 460-464 (1993).
3. Gorlin, R. J. Nevoid basal cell carcinoma syndrome. Dermatol. Clin., 13, 113-125 (1995).
4. Springate, J. E. The nevoid basal cell carcinoma syndrome. J. Pediatr. Surg., 21, 908-910 (1986).
5. Evans, D. G., Farndon, P. A., Burnell, L. D., Gattamaneni, H. R. and Birch, J. M. The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br. J. Canrer, 64, 959-961 (1991).
6. Gorlin, R. J. Nevoid basal-cell carcinoma syndrome. Medicine, 66, 98-113 (1987).
7. Atahan, I. L., Yildiz, F., Ozyar, E., Uzal, D. and Zorlu, F. Basal cell carcinomas developing in a case of medulloblastoma associated with Gorlin's syndrome. Pediatr. Hematol. Oncol., 15, 187-191 (1998).
8. Hahn, H., Wicking, C. Zaphiropoulous, P. G., Gailani, M. R., Shanley, S., Chidambaram, A., Vorechovsky, I., Holmberg, E., Unden, A. B., Gillies, S., Negus, K., Smyth, I., Pressman, C., Leffell, D. J., Gerrard, B., Goldstein, A. M., Dean, M., Toftgard, R., Chenevix-Trench, G., Wainwright, B. and Bale, A. E. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell, 85, 841-851 (1996).
9. Johnson, R. L., Rothman, A. L., Xie, J., Goodrich, L. V., Bare, J. W., Bonifas, J. M., Quinn, A. G., Myers, R. M., Cox, D. R., Epstein, E. H., Jr. and Scott, M. P. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science, 272, 1668-1671 (1996).
10. Chidambaram, A., Goldstein, A. M., Gailani, M. R., Gerrard, B., Bale, S. J., DiGiovanna, J. J., Bale, A. E. and Dean, M. Mutations in the human homologue of the Drosophila patched gene in Caucasian and African-American nevoid basal cell carcinoma syndrome patients. Cancer Res., 56, 4599-4601 (1996).
11. Gailani, M. R., Stahle-Backdahl, M., Leffell, D. J., Glynn, M., Zaphiropoulos, P. G., Pressman, C., Unden, A. B., Dean, M., Brash, D. E., Bale, A. E. and Toftgard, R. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nat. Genet., 14, 78-81 (1996).
12. Wicking, C., Shanley, S., Smyth, I., Gillies, S., Negus, K., Graham, S., Suthers, G., Haites, N., Edwards, M., Wainwright, B. and Chenevix-Trench, G. Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. Am. J. Hum. Genet., 60, 21-26 (1997).
13. Marigo, V., Davey, R. A., Zuo, Y., Cunningham, J. M. and Tabin, C. J. Biochemical evidence that patched is the hedgehog receptor. Nature. 384, 176-179 (1996).
14. Arlett, C. F. and Priestley, A. Deficient recovery from potentially lethal damage in some gamma-irradiated human fibroblast cell strains. Br. J. Cancer Suppl., 6, 227-232 (1984).
15. Featherstone, T., Taylor, A. M. and Harnden, D. G. Studies on the radiosensitivity of cells from patients with basal cell naevus syndrome. Am. J. Hum. Genet., 35, 58-66 (1983).
16. Applegate, L. A., Goldberg, L. H., Ley, R. D. and Ananthaswamy, H. N. Hypersensitivity of skin fibroblasts from basal cell nevus syndrome patients to killing by ultraviolet B but not by ultraviolet C radiation. Cancer Res., 50, 637-641 (1990).
17. Bassukus, I. D., Schell, H., Arai, A. and Hofmann, P. Hyposensitivity of basal cell naevus syndrome dermal fibroblasts to ultraviolet A. Lancet, 336, 8718 (1990).
18. Fujii, K., Suzuki, N., Ishijima, S., Kita, K., Sonoda, T., Dezawa, M., Sugita, K. and Niimi, H. Abnormal DNA synthesis activity induced by X-rays in nevoid basal cell carcinoma syndrome cells. Biochem. Biophys. Res. Commun., 240, 269-272 (1997).
19. Hahn, H., Wojnowski, L., Zimmer, A. M., Hall, J., Miller, G. and Zimmer, A. Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat. Med., 4, 619-622 (1998).
20. Kimonis, V. E., Goldstein, A. M., Pastakia, B., Yang, M. L., Kase, R., DiGiovanna, J. J., Bale, A. E. and Bale, S. J. Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome. Am. J. Med. Genet., 69, 299-308 (1997).
21. Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. G., Lin, H. K., Liebermann, D. A., Hoffman, B. and Reed, J. C. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene, 9, 1799-1805 (1994).
22. Polyak, K., Lee, M. H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P. and Massague, J. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 78, 59-66 (1994).
23. Toyoshima, H. and Hunter, T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell, 78, 67-74 (1994).
24. Xie, J., Murone, M., Luoh, S. M., Ryan, A., Gu, Q., Zhang, C., Bonifas, J. M., Lam, C. W., Hynes, M., Goddard, A., Rosenthal, A., Epstein, E. H., Jr. and deSauvage, F. J. Activating smoothened mutations in sporadic basal-cell carcinoma. Nature, 391, 90-92 (1998).
25. Reifenberger, J., Wolter, M., Weber, R. G., Megahed, M., Ruzicka, T., Lichter, P. and Reifenberger, G. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res., 58, 1798-1803 (1998).
26. Goi, K., Takagi, M., Iwata, S., Delia, D., Asada, M., Donghi, R., Tsunematsu, Y., Nakazawa, S., Yamamoto, H., Yokota, J., Tamura, K., Saeki, Y., Utsunomiya, J., Takahashi, T., Ueda, R., Ishioka, C., Eguchi, M., Kamata, N. and Mizutani, S. DNA damage-associated dysregulation of the cell cycle and apoptosis control in cells with germ-line p53 mutation. Cancer Res., 57, 1895-1902 (1997).
27. Takagi, M., Delia, D., Chessa, L., Iwata, S., Shigeta, T., Kanke, Y., Goi, K., Asada, M., Eguchi, M., Kodama, C. and Mizutani, S. Defective control of apoptosis, radiosensitivity, and spindle checkpoint in ataxia telangiectasia. Cancer Res., 58, 4923-4929 (1998).
28. CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell, 82, 675-684 (1995).
29. Treisman, J. E., Lai, Z. C. and Rubin, G. M. Shortsighted acts in the decapentaplegic pathway in Drosophila eye development and has homology to a mouse TGF-beta-responsive gene. Development, 121, 2835-2845 (1995).
30. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell, 85, 707-720 (1996).
31. Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H. and Elledge, S. J. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science, 277, 1497-1501 (1997).
32. Peng, C. Y., Graves, P. R., Thomas, R. S., Wu, Z., Shaw, A. S. and Piwnica-Worms, H. Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science, 277, 1501-1505 (1997).
33. Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W. and Vogelstein, B. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol. Cell, 1, 3-11 (1997).
34. Lloyd, R. V., Erickson, L. A., Jin, L., Kulig, E., Qian, X., Cheville, J. C. and Scheithauer, B. W. p27kipl: a multi-functional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am. J. Pathol., 154, 313-323 (1999).
35. Catzavelos, C., Tsao, M. S., DeBoer, G., Bhattacharya, N., Shepherd, F. A. and Slingerland, J. M. Reduced expression of the cell cycle inhibitor p27Kipl in non-small cell lung carcinoma: a prognostic factor independent of Ras. Cancer Res., 59, 684-688 (1999).